240 related articles for article (PubMed ID: 5589916)
1. [Hyperlipidemias: occurrence, significance, therapy].
Knüchel F
Med Welt; 1967 Aug; 32():1848-60. PubMed ID: 5589916
[No Abstract] [Full Text] [Related]
2. Blood lipids and lipoproteins in atherogenesis.
Brown DF
Am J Med; 1969 May; 46(5):691-704. PubMed ID: 4892338
[No Abstract] [Full Text] [Related]
3. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G
Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081
[No Abstract] [Full Text] [Related]
4. [Clinical-experimental studies on lipid metabolism using Regelan].
Hammerl H
Wien Klin Wochenschr; 1967 Sep; 79(39):720-2. PubMed ID: 4875575
[No Abstract] [Full Text] [Related]
5. [Association of neomycin sulfate and ethyl-p-chlorophenoxybutyrate in the treatment of dyslipemia].
Bertulla A; Bertamino V; Solari E
Ateneo Parmense 1; 1971; 42(2):103-14. PubMed ID: 5154400
[No Abstract] [Full Text] [Related]
6. [Importance of the clofibrat in the treatment of lipid metabolism disorders].
Laubinger G
Med Klin; 1968 Jan; 63(4):139-42. PubMed ID: 5670163
[No Abstract] [Full Text] [Related]
7. Atromid-S for the reduction of plasma lipids.
Med Lett Drugs Ther; 1967 Jun; 9(12):45-7. PubMed ID: 6037633
[No Abstract] [Full Text] [Related]
8. [Influence of beta-benzabutyramide on the blood lipids and on the thrombodensitogram].
Ferri F; Regazzini A; Pedini G
G Gerontol; 1970 Mar; 18(3):203-18. PubMed ID: 5473222
[No Abstract] [Full Text] [Related]
9. [Action mechanism and clinical success of Regelan (Clofibrate)].
Fitzgerald JD
Wien Klin Wochenschr; 1967 Sep; 79(39):716-20. PubMed ID: 5595437
[No Abstract] [Full Text] [Related]
10. [Prolonged use of atromid in patients with coronary arteriosclerosis].
Zadionchenko VS
Kardiologiia; 1967 Oct; 7(10):32-5. PubMed ID: 5607197
[No Abstract] [Full Text] [Related]
11. Treatment of essential hyperlipidaemia.
Jepson EM; Fahmy MF; Torrens PE; Billimoria JD; Maclagan NF
Lancet; 1969 Dec; 2(7634):1315-9. PubMed ID: 4188089
[No Abstract] [Full Text] [Related]
12. [Atherosclerosis and Regelan].
Schwaar R
Praxis; 1966 Aug; 55(31):875-80. PubMed ID: 5953569
[No Abstract] [Full Text] [Related]
13. Observations on the effect of ethyl a-p chlorophenoxyisobutyrate (CPIB) therapy on serum lipid levels and on diabetic and some other retinopathies.
Vannas S; Esilä R; Tuovinen E
Acta Ophthalmol (Copenh); 1968; 46(2):162-70. PubMed ID: 5755673
[No Abstract] [Full Text] [Related]
14. [Effect of Atromid on blood lipids in patients with hyperlipemia].
Baranova LV
Ter Arkh; 1968 Mar; 40(3):15-20. PubMed ID: 4875984
[No Abstract] [Full Text] [Related]
15. [Clinical contribution to the study of the eulipemic effect of 2 ethyl esters of p-chlorophenoxyisobutyric acid].
De Michelis S; Paparella P; Seu V
Clin Ter; 1969 Jul; 50(1):11-26. PubMed ID: 4917326
[No Abstract] [Full Text] [Related]
16. Essential hyperlipemia with xanthomatosis: effects of cholestyramine and clofibrate.
Roe DA
Arch Dermatol; 1968 Apr; 97(4):436-45. PubMed ID: 5643239
[No Abstract] [Full Text] [Related]
17. [Long-term treatment of previously therapy-resistant cases of primary hypertriglyceridemia of the adult with ethyl-p-chlorophenoxyisobutyrate].
Braunsteiner H; Herbst M; Sandhofer F; Sailer S
Dtsch Med Wochenschr; 1967 Dec; 92(50):2302-8. PubMed ID: 6075896
[No Abstract] [Full Text] [Related]
18. Long-term therapy of adult cases of primary hypertriglyceridaemia with clofibrate (ethyl-p-chlorophenoxyisobutyrate).
Braunsteiner H; Herbst M; Sandhofer F; Sailer S
Ger Med Mon; 1968 Feb; 13(2):65-72. PubMed ID: 5653144
[No Abstract] [Full Text] [Related]
19. Divergent effects in the treatment of hyperlipemia.
Slowe IA; Carter AC; Feldman EB
Arch Intern Med; 1965 Oct; 116(4):523-30. PubMed ID: 5835355
[No Abstract] [Full Text] [Related]
20. [Antilipidemic activity of ethyl-chloro-phenoxy-isobutyrate or clofibrate].
Barisone D; Gallo G; Accardo S
Minerva Med; 1969 Jan; 60(6):174-80. PubMed ID: 5776766
[No Abstract] [Full Text] [Related]
[Next] [New Search]
